近年来,在体外诱导活化的T淋巴细胞用于过继性免疫治疗成为热点,如CAR-T、TIL疗法等。常使用抗CD3抗体和抗CD28抗体或CD3/CD28抗体偶联磁珠模拟体内第一和第二刺激信号过程来激活T细胞,尤其是CD3/CD28抗体偶联磁珠,具有激活作用更强、可保留更多T细胞记忆表型、T细胞耗竭更少以及临床疗效更加持久等有优势,是细胞治疗药物开发过程中不可或缺的重要原料。
ACROBiosystems百普赛斯专注于支持细胞疗法相关研究,在完善的细胞培养平台、磁珠偶联技术平台、流式细胞分析平台下,开发出高质量的CD3/CD28抗体偶联磁珠产品(货号:MBS-C001 ),经全方位活性验证,可高效刺激扩增T细胞,助力您的细胞治疗药物开发进程。
★ 集分选激活于一体,省时高效
★ 兼容多款常用培养基,无忧培养
★ 可保留更多初始&记忆T细胞表型
★ 轻松分离不易残留;高安全和高稳定性
★ 已完成FDA DMF备案,助力药物申报
✍ T细胞激活验证
Fig. 1. Activation efficiency of human T cells was evaluated by flow cytometry using activation markers CD25 and CD69. Cells were evaluated 24 hours after stimulation and compared. (A) Negative control, (B) ACROBiosystems CD3/CD28 beads (Cat. No. MBS-C001) and (C) competitor products were compared. ACROBiosystems CD3/CD28 beads show superior activation rates compared to competitor’s T cell activation beads.
✍ T细胞扩增效果
Fig. 2. Performances of CD3/CD28 magnetic beads from different brands were compared in a human T cell expansion study. The results show that under each brand’s respective recommended conditions, ACROBiosystems’ CD3/CD28 beads have improved proliferative capabilities.
✍ 培养基兼容性验证
Fig. 3. Purified human T cells from a single donor were activated using ACROBiosystems CD3/CD28 Beads (Cat. No. MBS-C001) and expanded for 2 weeks in four different, commonly used cell medias supplemented with Human IL-2 (Cat. No. IL2-H5215, 4ng/mL). High cell viabilities and fold expansions were observed, highlighting compatibility with most types of cell media.
✍ T细胞分选结果
Fig. 4. Comparison of CD3+ T cell isolation capabilities of ACROBiosytems CD3/CD28 beads (Cat. No. MBS-C001) against competitor product using human PBMCs. (A) The PBMC population was used as a control, with the unbound cell population remaining in the cell supernatant being evaluated. Isolation was performed using (B) ACROBiosystem CD3/CD28 beads and (C) competitor products (Competitor T) for comparison. Residual CD3+ T cells remaining in the supernatant was evaluated through FACS, revealing a lower percentage of non-isolated CD3+ T cells. (D) Recovery rate of CD3+ T cells were also compared, showing no losses in isolation efficiency with (E) a high level of CD3+ T cell population purity.
✍ T细胞表型分析
Fig. 5. Cell characterization, composition, and PD-1 expression after expansion was performed and compared for both ACROBiosystem CD3/CD28 beads (Cat. No. MBS-C001) and competitor beads (Competitor T). Isolated human CD3+ T cells were cultured for 13 days and analyzed. (A) On day 13, cell composition (naïve T cells, Tn; T memory stem cells, Tscm; central memory T cells, Tcm; effector memory T cells, Tem; terminal effector T cells, Tte) were evaluated using flow cytometry. Expansion performed using ACROBiosystem CD3/CD28 beads resulted in improved percentage of naïve T cells while minimizing Tte cells. (B) PD-1, a surface marker for cell exhaustion, was also evaluated with ACROBiosystems’ beads having lower PD-1 expression and thus, lower cell exhaustion through the cell expansion process.
很开心ACRO的产品能够真正帮助到大家,我们会继续努力,做出更优秀的产品,更好的服务客户,如果你也使用了ACRO的产品,欢迎留下你的产品评论,有机会获得星巴克咖啡券哦~
明星产品:CD3/CD28抗体偶联磁珠(Cat. No. MBS-C001)
更多相关产品
参考文献
1. Hollyman D, Stefanski J, PrzybylowskiM, Bartido S, Borquez- Ojeada O, Taylor C, Yeh R, Capacio V, Olszewska M, HoseyJ et al.: Manufacturing validation of biologically functional T cells targetedto CD19 antigen for autologous adoptive cell therapy. J Immunother 2009, 32:169-180.
2. Casati A, Varghaei-Nahvi A, FeldmanSA, Assenmacher M, Rosenberg SA, Dudley ME, Scheffold A: Clinical-scaleselection and viral transduction of human naı¨ve and central memory CD8+ T cells for adoptive cell therapy ofcancer patients. Cancer Immunol Immunother 2013, 62:1563-1573.
3. Barrett DM, Singh N, Liu X, JiangS, June CH, Grupp SA, Zhao Y: Relation of clinical culture method to T-cellmemory status and efficacy in xenograft models of adoptive immunotherapy. Cytotherapy2014, 16:619-630.
ACROBiosystems百普赛斯生物科技股份有限公司
北京:010-53681107
上海:021-50850665
邮箱:(产品订购)order.cn@acrobiosystems.com
邮箱:(技术支持)tech.cn@acrobiosystems.com
邮箱:(廉洁合规)lianjie@acrobiosystems.com
地址:北京经济技术开发区宏达北路8号5号楼4层